Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies
Gabriele Cerutti, Micah Rapp, Yicheng Guo, Fabiana Bahna, Jude Bimela, Eswar R. Reddem, Jian Yu, Pengfei Wang, Lihong Liu, Yaoxing Huang, David D. Ho, Peter D. Kwong, Zizhang Sheng, Lawrence Shapiro
Topics & Concepts
NeutralizationEpitopeAntibodyMonoclonal antibodyVirologyNeutralizing antibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologyImmune escapeImmune systemCoronavirus disease 2019 (COVID-19)ImmunologyMedicineInfectious disease (medical specialty)DiseasePathologySARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingBacillus and Francisella bacterial research